Liminatus Pharma, Inc. - Class A Common Stock

Share · US53271X1081 · LIMN (XNAS)

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Liminatus Pharma, Inc. - Class A Common Stock

No Price

21.04.2026 10:31

Current Prices from Liminatus Pharma, Inc. - Class A Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	LIMN	USD	21.04.2026 10:31	0,22 USD	0,002 USD +1,12 %
IEX	LIMN	USD	20.04.2026 19:40	0,21 USD	-0,02 USD -9,79 %

Share Float & Liquidity

Free Float 30,09 %

Shares Float 8,07 M

Shares Outstanding 26,83 M

Company Profile for Liminatus Pharma, Inc. - Class A Common Stock Share

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.

Company Data

Name Liminatus Pharma, Inc. - Class A Common Stock

Company Liminatus Pharma, Inc. Class A Common Stock

Symbol LIMN

Website https://liminatuspharma.com

Primary Exchange

NASDAQ

ISIN US53271X1081

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Chris Kim

Country United States of America

Currency USD

Employees 0,0 T

Address 6 Centerpointe Drive, 90623 La Palma

IPO Date 2025-05-01

Ticker Symbols

Name	Symbol
NASDAQ	LIMN

More Shares

Investors who hold Liminatus Pharma, Inc. - Class A Common Stock also have the following shares in their portfolio:

LB.HESS.THR.CARRAR 03G/21 Bond

PTT OIL+RET.BUS.-NVDR- 10 Share